{"DataElement":{"publicId":"2540958","version":"1","preferredName":"AIDS Malignancy Consortium Patient Exclusion Clinical Trial Eligibility Criteria 047 Type","preferredDefinition":"the type of element of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by NCI.","longName":"AMC_PT_E_CTEC_047_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2518234","version":"1","preferredName":"AIDS Malignancy Consortium Patient Exclusion Clinical Trial Eligibility Criteria","preferredDefinition":"information relating to the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by the NCI.","longName":"AMC_PT_EXCLU_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2518228","version":"1","preferredName":"AIDS Malignancy Consortium Patient","preferredDefinition":"Established in 1995 to carry out Phase I and II studies of innovative therapies for AIDS malignancies.:A person who requires medical care.","longName":"C19707:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS Malignancy Consortium","conceptCode":"C19707","definition":"Established in 1995 to carry out Phase I and II studies of innovative therapies for AIDS malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC96D39-08C6-6793-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2518232","version":"1","preferredName":"Exclusion Clinical Trial Eligibility Criteria","preferredDefinition":"Exclusion; the act of restricting entrance or barring from participation.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C25370:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exclusion Criteria","conceptCode":"C25370","definition":"Medical and/or social characteristics that prevent a subject from being allowed to participate in a clinical study, as outlined in the study protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC88111-1844-69E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC88111-1855-69E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2540946","version":"1","preferredName":"047 Exclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of clinical trial eligibility exclusion criteria for an AIDS Malignancy Consortium 047 protocol.","longName":"047_EXCL_CTEC_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"255","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"If the patient is a female, is she pregnant or nursing?","valueDescription":"If the patient is a female, is she pregnant or nursing?","ValueMeaning":{"publicId":"2580750","version":"1","preferredName":"If the patient is a female, is she pregnant or nursing?","longName":"2580750","preferredDefinition":"If the patient is a female, is she pregnant or nursing?","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-087B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"SHIDED","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21E93551-05C1-4A6C-E044-0003BA3F9857","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Does the subject have a second active tumor, other than non-melanomatous skin cancer, carcinoma in situ of the cervix or Kaposi's sarcoma that does not require systemic therapy","valueDescription":"Does the subject have a second active tumor, other than non-melanomatous skin cancer, carcinoma in situ of the cervix or Kaposi's sarcoma that does not require systemic therapy","ValueMeaning":{"publicId":"2581731","version":"1","preferredName":"Does the subject have a second active tumor, other than non-melanomatous skin cancer, carcinoma in situ of the cervix or Kaposi's sarcoma that does not require systemic therapy","longName":"2581731","preferredDefinition":"Does the subject have a second active tumor, other than non-melanomatous skin cancer, carcinoma in situ of the cervix or Kaposi's sarcoma that does not require systemic therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C50-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"SHIDED","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EA73CA-1D8B-0A19-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Does the subject have primary CNS lymphoma (this includes parenchymal brain or spinal chord lymphoma)","valueDescription":"Does the subject have primary CNS lymphoma (this includes parenchymal brain or spinal chord lymphoma)","ValueMeaning":{"publicId":"2581732","version":"1","preferredName":"Does the subject have primary CNS lymphoma (this includes parenchymal brain or spinal chord lymphoma)","longName":"2581732","preferredDefinition":"Does the subject have primary CNS lymphoma (this includes parenchymal brain or spinal chord lymphoma)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C51-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"SHIDED","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EA73CA-1D9D-0A19-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Does the subject have leptomeningeal disease (positive CSF for lymphoma) or a presence of metastatic disease of the brain in terms of any mass lesion","valueDescription":"Does the subject have leptomeningeal disease (positive CSF for lymphoma) or a presence of metastatic disease of the brain in terms of any mass lesion","ValueMeaning":{"publicId":"2581733","version":"1","preferredName":"Does the subject have leptomeningeal disease (positive CSF for lymphoma) or a presence of metastatic disease of the brain in terms of any mass lesion","longName":"2581733","preferredDefinition":"Does the subject have leptomeningeal disease (positive CSF for lymphoma) or a presence of metastatic disease of the brain in terms of any mass lesion","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C52-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"SHIDED","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EA73CA-1DAF-0A19-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Is the subject's expected survival < 2 months","valueDescription":"Is the subject's expected survival < 2 months","ValueMeaning":{"publicId":"2581734","version":"1","preferredName":"Is the subject's expected survival < 2 months","longName":"2581734","preferredDefinition":"Is the subject's expected survival < 2 months","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C53-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"SHIDED","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EA73CA-1DC1-0A19-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"In the opinion of the Principal Investigator, is the subject unable to comply with the requirements of the protocol, or unable to provide adequate informed consent","valueDescription":"In the opinion of the Principal Investigator, is the subject unable to comply with the requirements of the protocol, or unable to provide adequate informed consent","ValueMeaning":{"publicId":"2581735","version":"1","preferredName":"In the opinion of the Principal Investigator, is the subject unable to comply with the requirements of the protocol, or unable to provide adequate informed consent","longName":"2581735","preferredDefinition":"In the opinion of the Principal Investigator, is the subject unable to comply with the requirements of the protocol, or unable to provide adequate informed consent","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C54-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"SHIDED","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EA73CA-1DD3-0A19-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Does the subject have a serious, ongoing, non-malignant disease or infection, which, in the opinion of the Investigator and/or Sponsor, would compromise protocol objectives","valueDescription":"Does the subject have a serious, ongoing, non-malignant disease or infection, which, in the opinion of the Investigator and/or Sponsor, would compromise protocol objectives","ValueMeaning":{"publicId":"2581736","version":"1","preferredName":"Does the subject have a serious, ongoing, non-malignant disease or infection, which, in the opinion of the Investigator and/or Sponsor, would compromise protocol objectives","longName":"2581736","preferredDefinition":"Does the subject have a serious, ongoing, non-malignant disease or infection, which, in the opinion of the Investigator and/or Sponsor, would compromise protocol objectives","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C55-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"SHIDED","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21E9C300-6C22-08F2-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Has the subject had any major surgery (excluding diagnostic surgery) within the 4 weeks prior to study entry","valueDescription":"Has the subject had any major surgery (excluding diagnostic surgery) within the 4 weeks prior to study entry","ValueMeaning":{"publicId":"2581737","version":"1","preferredName":"Has the subject had any major surgery (excluding diagnostic surgery) within the 4 weeks prior to study entry","longName":"2581737","preferredDefinition":"Has the subject had any major surgery (excluding diagnostic surgery) within the 4 weeks prior to study entry","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C56-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"SHIDED","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21E9C300-6C34-08F2-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Has the subject received rituximab therapy within the 12 months prior to study entry","valueDescription":"Has the subject received rituximab therapy within the 12 months prior to study entry","ValueMeaning":{"publicId":"2581738","version":"1","preferredName":"Has the subject received rituximab therapy within the 12 months prior to study entry","longName":"2581738","preferredDefinition":"Has the subject received rituximab therapy within the 12 months prior to study entry","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C57-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"SHIDED","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21E9C300-6C46-08F2-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Does the subject have a history of cytotoxic chemotherapy or radiotherapy for this lymphoma","valueDescription":"Does the subject have a history of cytotoxic chemotherapy or radiotherapy for this lymphoma","ValueMeaning":{"publicId":"2581739","version":"1","preferredName":"Does the subject have a history of cytotoxic chemotherapy or radiotherapy for this lymphoma","longName":"2581739","preferredDefinition":"Does the subject have a history of cytotoxic chemotherapy or radiotherapy for this lymphoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C58-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"SHIDED","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21E9C300-6C58-08F2-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Does the subject have history of cutaneous or mucocutaneous reactions or diseases, due to any cause, severe enough to cause hospitalization or an inability to eat or drink for >= 2 days","valueDescription":"Does the subject have history of cutaneous or mucocutaneous reactions or diseases, due to any cause, severe enough to cause hospitalization or an inability to eat or drink for >= 2 days","ValueMeaning":{"publicId":"2581740","version":"1","preferredName":"Does the subject have history of cutaneous or mucocutaneous reactions or diseases, due to any cause, severe enough to cause hospitalization or an inability to eat or drink for >= 2 days","longName":"2581740","preferredDefinition":"Does the subject have history of cutaneous or mucocutaneous reactions or diseases, due to any cause, severe enough to cause hospitalization or an inability to eat or drink for >= 2 days","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C59-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"SHIDED","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21E9C300-6C6A-08F2-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Is the subject receiving zidovudine as part of the HARRT regimen","valueDescription":"Is the subject receiving zidovudine as part of the HARRT regimen","ValueMeaning":{"publicId":"2581742","version":"1","preferredName":"Is the subject receiving zidovudine as part of the HARRT regimen","longName":"2581742","preferredDefinition":"Is the subject receiving zidovudine as part of the HARRT regimen","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C5B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"SHIDED","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21E9CF0A-343B-0A9E-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Does the subject have an acute, intercurrent infection (excluding Mycobacterium avium) that may interfere with planned protocol treatment","valueDescription":"Does the subject have an acute, intercurrent infection (excluding Mycobacterium avium) that may interfere with planned protocol treatment","ValueMeaning":{"publicId":"2581744","version":"1","preferredName":"Does the subject have an acute, intercurrent infection (excluding Mycobacterium avium) that may interfere with planned protocol treatment","longName":"2581744","preferredDefinition":"Does the subject have an acute, intercurrent infection (excluding Mycobacterium avium) that may interfere with planned protocol treatment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C5D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"SHIDED","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21E9CF0A-344D-0A9E-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Does the subject have inadequate pulmonary function (i.e., shortness of breath at rest, with arterial PO\\2 < 70 or pulse oximeter-derived O\\2 saturation < 94% on room air [unless due to lymphomatous involvement of the lungs])","valueDescription":"Does the subject have inadequate pulmonary function (i.e., shortness of breath at rest, with arterial PO\\2 < 70 or pulse oximeter-derived O\\2 saturation < 94% on room air [unless due to lymphomatous involvement of the lungs])","ValueMeaning":{"publicId":"2581745","version":"1","preferredName":"Does the subject have inadequate pulmonary function (i.e., shortness of breath at rest, with arterial PO\\2 < 70 or pulse oximeter-derived O\\2 saturation < 94% on room air [unless due to lymphomatous involvement of the lungs])","longName":"2581745","preferredDefinition":"Does the subject have inadequate pulmonary function (i.e., shortness of breath at rest, with arterial PO\\2 < 70 or pulse oximeter-derived O\\2 saturation < 94% on room air [unless due to lymphomatous involvement of the lungs])","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C5E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"SHIDED","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21E9CF0A-345F-0A9E-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Has the subject had a myocardial infarction (MI) within the 6 months prior to study entry, New York Heart Association (NYHA) Class II or greater heart failure, uncontrolled angina, severe uncontrolled ventricular arrhythmias, clinically significant","valueDescription":"Has the subject had a myocardial infarction (MI) within the 6 months prior to study entry, New York Heart Association (NYHA) Class II or greater heart failure, uncontrolled angina, severe uncontrolled ventricular arrhythmias, clinically significant","ValueMeaning":{"publicId":"2581746","version":"1","preferredName":"Has the subject had a myocardial infarction (MI) within the 6 months prior to study entry, New York Heart Association (NYHA) Class II or greater heart failure, uncontrolled angina, severe uncontrolled ventricular arrhythmias, clinically significant","longName":"2581746","preferredDefinition":"Has the subject had a myocardial infarction (MI) within the 6 months prior to study entry, New York Heart Association (NYHA) Class II or greater heart failure, uncontrolled angina, severe uncontrolled ventricular arrhythmias, clinically significant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C5F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"SHIDED","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21E9A64C-A069-0668-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Is the subject already receiving erythropoietin or G-CSF for treatment of HIV-related cytopenia If yes, will growth factors be discontinued at least 24 hours prior to chemotherapy","valueDescription":"Is the subject already receiving erythropoietin or G-CSF for treatment of HIV-related cytopenia If yes, will growth factors be discontinued at least 24 hours prior to chemotherapy","ValueMeaning":{"publicId":"3006954","version":"1","preferredName":"Is the subject already receiving erythropoietin or G-CSF for treatment of HIV-related cytopenia If yes, will growth factors be discontinued at least 24 hours prior to chemotherapy","longName":"3006954","preferredDefinition":"Is the subject already receiving erythropoietin or G-CSF for treatment of HIV-related cytopenia If yes, will growth factors be discontinued at least 24 hours prior to chemotherapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EDCA7F0-378D-E0D4-E040-BB89AD4357F0","latestVersionIndicator":"Yes","beginDate":"2010-02-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EDCA7F0-37A6-E0D4-E040-BB89AD4357F0","beginDate":"2010-02-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-02-05","modifiedBy":"ONEDATA","dateModified":"2010-02-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"21E93551-057A-4A6C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"SHIDED","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Exclusion Criteria","type":"Preferred Question Text","description":"Exclusion Criteria","url":null,"context":"CTEP"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"21E9E80D-EEAC-140D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-10","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}